Carboxypeptidase-G2 Rescue in a Patient with High Dose Methotrexate-induced Nephrotoxicity
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A 13 year-old girl with osteosarcoma and pulmonary tumor recurrence developed acute renal failure following high dose methotrexate (12 g/m2) therapy, she had previously tolerated high dose methotrexate and her renal and hepatic functions were normal. Briefly, 48 hours after beginning methotrexate infusion her methotrexate concentration and creatinine level were 1338.8μM/L and 5.8 mg/dl, respectively. Grade IV oral mucositis and neutropenia with fever developed at 144 hours after MTX infusion. Hydration and alkalinization were continued and leucovorin rescue was intensified based on the plasma MTX concentrations. Plasma exchange was performed twice and hemodialysis 3 times without problems, but methotraxate and creatinine levels remained high, 91.9 μM/L, and 2.5 mg/dl, respectively. After 3 courses of hemodialysis carboxypeptidase-G2 (CPDG2) was administered at 50 U/kg, intravenously over 5 minutes. After 15 minutes of CPDG2 (VoraxazeTM) infusion, her plasma MTX concentration was 0.91μM/L and no rebound elevation or side effects developed. Thirteen days post-MTX infusion her renal function had normalized. We report here our experience of a dramatic methotrexate level reduction caused by CPDG2 administration.
Abstract
A 13 year-old girl with osteosarcoma and pulmonary tumor recurrence developed acute renal failure following high dose methotrexate (12 g/m2) therapy, she had previously tolerated high dose methotrexate and her renal and hepatic functions were normal. Briefly, 48 hours after beginning methotrexate infusion her methotrexate concentration and creatinine level were 1338.8μM/L and 5.8 mg/dl, respectively. Grade IV oral mucositis and neutropenia with fever developed at 144 hours after MTX infusion. Hydration and alkalinization were continued and leucovorin rescue was intensified based on the plasma MTX concentrations. Plasma exchange was performed twice and hemodialysis 3 times without problems, but methotraxate and creatinine levels remained high, 91.9 μM/L, and 2.5 mg/dl, respectively. After 3 courses of hemodialysis carboxypeptidase-G2 (CPDG2) was administered at 50 U/kg, intravenously over 5 minutes. After 15 minutes of CPDG2 (VoraxazeTM) infusion, her plasma MTX concentration was 0.91μM/L and no rebound elevation or side effects developed. Thirteen days post-MTX infusion her renal function had normalized. We report here our experience of a dramatic methotrexate level reduction caused by CPDG2 administration.
참고문헌 (13)
- "The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy", 9, pp.133~42 (1980)
- "High-dose leucovorin as sole therapy for methotrexate toxicity", 17, pp.1589~94 (1999)
- "Removal of methotrexate,leucovorin,and their metabolites by combined hemodialysis and hemoperfusion", 62, pp.884~8 (1988)
- "A case of methotrexate-induced acute renal failure successfully treated with plasma perfusion and sequential hemodialysis", 71, pp.233~4 (1995)
- "Molecular cloning of the Pseudomonas carboxypeptidase G2 gene and its expression in Escherichia coli and Pseudomonas putida", 156, pp.1222~7 (1983)
- "Pharmacokinetics and metabolism of the methotrexate metabolite,2,4-diamino-N10-methylpteroic acid", 294, pp.894~901 (2000)
- "Preoperative chemotherapy for osteogenic sarcoma:selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperativechemotherapy", 49, pp.1221~30 (1982)
- "High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma", 100, pp.2222~32 (2004)
- "Efficacy of pre- and postoperative chemotherapy in patients with osteosarcoma of the extremities", 33, pp.520~6 (2001)
- "A case of high dose methotrexate-induced acute renal failure successfully treated with plasma exchange and hemodialysis", 35, pp.58~61 (2000)
- "Continuous plasma resin perfusion for detoxification of methotrexate", 156, pp.533~6 (1997)
- "Removal of methotrexate by continuous venovenous hemodiafiltration", 116, pp.48~52 (1995)
- "Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.", 15, pp.2125~34 (1997)